Carl Johan Spak

Dr. Spak is Senior Advisor at Flerie Invest. He has held a number of positions in pharma companies and currently serves as director of several drug development companies, among them KAHR Medical, Atrogi, Symcel and Xspray Pharma.

He had a long career within Recipharm, one of the leading CDMOs in the pharma space, where he has served in several executive roles over 25 years.

Dr. Spak has a PhD in pharmacology and cariology from the Karolinska Institute in Sweden.